EHA-Patient Joint Symposium – EHA2021 Virtual

Part 1: Wednesday, June 9, 13:00-16:00 CET

What are the prospects for improving affordable access in two areas of key importance to hematology – precision diagnostics and orphan medicines?

• 13:00-14:15 CET SESSION I  Coming to haematology soon: Diagnostic regulations – Threat or opportunity for innovative diagnostics ?  
• 14:30-15:45 CET SESSION II  Affordable access to orphan medicines [or: Fair pricing of orphan medicines] 

Part 2: Friday, June 11, 13:00-14:00 CET

Which lessons from the pandemic can help to improve research, approvals, evidence generation and clinical practice? 

• 13:00-14:00 CET SESSION III: Lessons from COVID  

Part 3: Saturday, June 12, 10:00-12:45 CET

Routine implementation of personalized therapies requires innovative trial designs and dedicated, more flexible regulatory frameworks.

• 10:00-11:15 AM CET SESSION IV: Personalized Medicine Trials
• 11:30-12:45 CET SESSION V: Reducing Bureaucracy in Clinical Trials